Am J Transplant, Volume 20, Suppl 3 Archives - Page 213 of 223 - ATC Abstracts

2020 American Transplant Congress
Low Mycophenolic Acid Levels are Associated with More Inflammation on 1 Year Protocol Biopsies and Lower Graft Survival in Kidney Transplant Recipients
J. Huskey, G. Mour, M. Ryan, S. Nair, M. Smith, R. Heilman
Mayo Clinic Arizona, Phoenix, AZ
*Purpose: Data is limited on the association of Mycophenolic Acid (MPA) concentration on protocol kidney transplant biopsies. Our aim is to compare clinical outcomes and…
2020 American Transplant Congress
Validation of Single Nucleotide Polymorphisms for Acute Renal Graft Rejection
H. Hwang¹, J. Kong¹, J. Kim¹, Y. Kim¹, J. Moon¹, K. Jeong¹, J. Park², J. Park³, T. Ban⁴, J. Yang⁵, C. Ahn⁶, S. Lee¹
¹Division of Nephrology, Department of Internal Medicine, College of Medicine, Kyung Hee University, Seoul, Korea, Republic of, ²Konkuk University School of Medicine, Seoul, Korea, Republic of, ³Yeungnam University Hospital, Seoul, Korea, Republic of, ⁴Eunpyeong St. Mary's Hospital The Catholic University of Korea, College of Medicine, Seoul, Korea, Republic of, ⁵Department of Surgery, Seoul National University Hospital, Seoul, Korea, Republic of, ⁶Division of Nephrology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of
*Purpose: Genome-wide association studies (GWAS) has identified potential single nucleotide polymorphisms (SNPs), which is associated with acute rejection in renal transplant recipients. We sought to…
2020 American Transplant Congress
Single Port Robot Assisted Kidney Transplantation
E. Miller, C. Wilson, G. Sawczyg, S. Kim, A. Aminsharifi, J. Garisto, J. Kaouk, A. Wee, M. Eltemamy
Glickman Urological and Kidney Institute CCF, Cleveland, OH
*Purpose: Innovative methods are needed to further optimize safe outcomes in kidney transplantation (KT), therefore as an alternative surgical approach we present a single case…
2020 American Transplant Congress
Impact of Rituximab and Apheresis Techniques in Acute Rejection Rates in ABO Incompatible Living Donor Kidney Transplant
I. Revuelta¹, E. De Sousa-Amorim¹, M. Lozano², D. Cucchiari¹, J. Cid², L. Peri³, E. Palou⁴, M. Musquera³, J. Martorell⁵, J. M. Campistol¹, F. Oppenheimer¹, F. Diekmann¹
¹Renal Transplant Unit, Department of Nephrology and Kidney Transplant, Hospital Clinic, Barcelona, Spain, ²Apheresis and Cellular Therapy Unit, Hospital Clinic, Barcelona, Spain, ³Department of Urology, Hospital Clinic, Barcelona, Spain, ⁴Histocompatibility Lab. Department of Immunology, Hospital Clinic, Barcelona, Spain, ⁵Histocompatibility Lab, Department of Immunology, Hospital Clinic, Barcelona, Spain
*Purpose: ABO incompatibility (ABOi) is a widespread option of living kidney donor transplantation (LKDT). However, controversies in rejection, and death-censored graft survival rates are published,…
2020 American Transplant Congress
Marginal Not So Marginal Anymore: Time for New Definitions for “Marginal” Allografts in Liver Transplantation?
T. Zhang¹, J. Dunson¹, F. Kanwal², T. Galvan², J. Vierling², C. O'Mahony², J. Goss², A. Rana²
¹Medical Student, Baylor College of Medicine, Houston, TX, ²Baylor College of Medicine, Houston, TX
*Purpose: We examined time trends in the outcomes of patients who received marginal liver allografts defined on the basis of the Donor Risk Index [DRI]…
2020 American Transplant Congress
Lose Weight to Donate Program: Preliminary Results of a Program Intended to Optimize Obese Living Donor Liver Candidates
J. Rose¹, T. Seay², A. Pesch³, P. Vargas⁴, S. Pelletier⁴, J. Oberholzer⁴, C. Argo⁵, N. Goldaracena⁴
¹School of Medicine, University of Virginia Health System, Charlottesville, VA, ²Division of Transplantation, University of Virginia Health System, Charlottesville, VA, ³Radiology Department, University of Virginia Health System, Charlottesville, VA, ⁴Department of Surgery, Division of Transplantation, University of Virginia Health System, Charlottesville, VA, ⁵Department of Medicine-Gastroenterology, University of Virginia Health System, Charlottesville, VA
*Purpose: Living donation (LD) can alleviate organ shortage, but is limited by obesity compromising organ quality and donor safety. This study intends to assess the…
2020 American Transplant Congress
Older Livers Should Not Be Utilized in Pediatric Liver Transplantation
M. MacConmara, C. Feizpour, A. Aqul, D. Desai, P. Vagefi, S. Hanish, L. DeGregorio, C. S. Hwang
UT Southwestern, Dallas, TX
*Purpose: Organ scarcity in liver transplantation has required expansion of the acceptable criteria used for donor selection. The utilization of older donors (>60 years) has…
2020 American Transplant Congress
Successful Use of Tedizolid for the Treatment of Nocardiosis in Transplant Recipients
R. Odrobina¹, B. Tritle², C. A.Gomez¹
¹Division of Infectious Diseases, University of Utah, Salt Lake City, UT, ²Department of Pharmacy, University of Utah, Salt Lake City, UT
*Purpose: Nocardiosis is an opportunistic infection occasionally seen after solid organ (SOT) and hematopoietic stem-cell transplantation. Treatment is challenging due to the limited number of…
2020 American Transplant Congress
Multi-Organ Procurement Organization Review of the Impact of Reactive Anti-HCV and HCV NAT Results
C. C. Muse, C. A. Hostetler, R. A. Squires, J. P. Orlowski
LifeShare Transplant Donor Services of Oklahoma, Oklahoma City, OK
*Purpose: Previously a single organ procurement organization (OPO) reviewed data from a 15 month cohort (1/1/2016 to 3/31/17) and concluded that donors who tested positive…
2020 American Transplant Congress
Hematopoietic Cell Transplantation and Solid Organ Transplantation: Outcomes of Sequential Transplantation in the United States
M. Gupta¹, M. Levine², D. Porter², R. Brazauskas³, S. Bo-Subait⁴, R. Phelan³, M. Battiwalla⁵, D. Buchbinder⁶, B. Hamilton⁷, B. Shaw³, P. Abt²
¹University of Kentucky, Lexington, KY, ²University of Pennsylvania, Philadelphia, PA, ³Medical College of Wisconsin, Milwaukee, WI, ⁴CIBMTR, NMDP, Minneapolis, MN, ⁵Sarah Cannon Blood Cancer Network, Nashville, TN, ⁶Children's Hospital of Orange County, Orange, CA, ⁷Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH
*Purpose: Survival after solid organ transplantation(SOT) and hematopoietic cell transplantation(HCT) has steadily risen. Despite these improvements, SOT recipients may develop conditions requiring HCT, and HCT…